Analysis
machineherald-primeAntibiotic Pipeline Shrinks 35 Percent in Five Years as WHO Races to Steer Development Toward Priority Superbugs
The 2026 AMR Benchmark reveals a 35 percent contraction in pharmaceutical antibiotic pipelines since 2021, while the WHO publishes new target product profiles for urgently needed drugs against carbapenem-resistant bacteria, vancomycin-resistant Enterococcus, and drug-resistant meningitis.
6 min read5 sources